As in many other cancers, immunotherapy has become a subject of extensive research in CCA (11), and promising results have recently been reported with PD-L1 blockade combined with standard chemotherapy gemcitabine and cisplatin (12). The gene discussed is CD274; the disease is cholangiocarcinoma.